辣椒素
医学
偏头痛
里扎曲普坦
三叉神经
月经周期
内科学
激光多普勒测速
血管舒张
麻醉
血流
内分泌学
激素
苏马曲普坦
受体
兴奋剂
作者
Khatera Ibrahimi,Willebrordus P. J. van Oosterhout,Wendy van Dorp,A.H. Jan Danser,Ingrid M. Garrelds,Steven A. Kushner,Emmanuel Lesaffre,Gisela M. Terwindt,Michel D. Ferrari,Anton H. van den Meiracker,Antoinette MaassenVanDenBrink
出处
期刊:Neurology
[Lippincott Williams & Wilkins]
日期:2014-12-11
卷期号:84 (2): 125-131
被引量:39
标识
DOI:10.1212/wnl.0000000000001142
摘要
A case-control study to investigate the effect of the menstrual cycle on trigeminal nerve-induced vasodilation in healthy women and patients with menstrually related migraine (MRM).Using a laser-Doppler imager, we compared the vasodilator effects of capsaicin application and electrical stimulation (ES) on the forehead skin, a trigeminal nerve-innervated dermatome, in premenopausal patients with MRM (n = 22), healthy controls (n = 20), and postmenopausal women without migraine (n = 22). Blood samples were collected for female sex hormone measurements.Dermal blood flow (DBF) responses to capsaicin were higher in controls during days 1-2 than during days 19-21 of their menstruation cycle (mean Emax ± SEM: 203 ± 28 AU vs 156 ± 27 AU [p = 0.031] for 0.06 mg/mL capsaicin and 497 ± 25 AU vs 456 ± 24 AU [p = 0.009] for 6.0 mg/mL capsaicin). In contrast, patients with MRM demonstrated DBF responses without significant cycle-dependent variability (days 1-2 vs days 19-21: Emax 148 ± 20 AU vs 154 ± 20 AU [p = 0.788] for 0.06 mg/mL capsaicin and 470 ± 17 AU vs 465 ± 20 AU [p = 0.679] for 6.0 mg/mL capsaicin). DBF responses to ES were not different between either patients with MRM or controls, at either occasion. Estradiol levels on days 19-21 of the menstrual cycle were higher in healthy controls (mean ± SEM: 75 ± 8 pg/mL) than in patients with MRM (52 ± 4 pg/mL, p = 0.014). In postmenopausal women, DBF responses to capsaicin and ES, as well as estradiol levels at both visits, were all significantly reduced compared to patients with MRM and controls (in all cases, p < 0.05).Our study provides evidence for a reduced menstrual cyclicity of both estradiol levels and the trigeminovascular vasodilator system in patients with MRM.
科研通智能强力驱动
Strongly Powered by AbleSci AI